Digoxin Injection
Product Images NDC 0641-6184

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 0641-6184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Digoxin Injection Novaplus 1)

Chemical structure of Digoxin, showing its steroid nucleus with attached sugar moieties and oxygen-containing functional groups, consistent with the digoxin molecule used in medication.*

FDA Label Image

West-ward Logo (Digoxin Injection Novaplus 2)

Digoxin injection USP 500 mcg per 2 mL (0.5 mg/2 mL or 250 mcg/mL) in a 2 mL ampul for intramuscular or intravenous use. The label includes the NDC 0641-6184-01 and states it is distributed by Hikma Pharmaceuticals USA Inc. The label also displays expiration and lot number fields.*

FDA Label Image

Container Label Digoxin Novaplus (Digoxin Injection Novaplus 3)

The packaging label for Digoxin Injection, USP 500 mcg per 2 mL (0.5 mg/2 mL or 250 mcg/mL) by Hikma Pharmaceuticals USA Inc. It indicates use for slow intravenous or deep intramuscular administration, with no dilution required. The package contains 25 ampuls of 2 mL each. Additional text includes ingredients, storage instructions, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.